AOD-9604 vs NAD+ — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic fragment of human growth hormone (hGH), specifically the C-terminal region spanning amino acids 176-191 with an additional tyrosine at position 177. It was designed to isolate the fat-metabolizing properties of hGH without the IGF-...
Calculate AOD-9604 dose →NAD+ is a coenzyme present in every cell, essential for mitochondrial ATP production via electron transport, DNA repair via PARP enzymes, and sirtuin deacetylase activation. Levels decline approximately 50% between age 20 and 60. Restored through IV therapy or oral precursors NMN...
Calculate NAD+ dose →| Parameter | AOD-9604 | NAD+ |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Phase IIb (Discontinued) | Widely Studied |
| Half-Life | ~30 minutes | Very short (direct IV); precursors have hours-long kinetics |
| Typical Dose | 300 µg | 250–1,000 mg (IV) |
| Frequency | Once daily (fasted) | 2–3x weekly (IV therapy); daily (oral precursors) |
| Route | Subcutaneous / Oral | IV / IM / Oral (as precursors NMN, NR) |
| FDA Status | Not Approved | Not Approved (drug use) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.